Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

formoterol

Known as: Formoterol [Chemical/Ingredient], Eformoterol, 2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide 
A long-acting beta-adrenergic receptor agonist with bronchodilator activity. Formoterol selectively binds to beta-2 adrenergic receptors in bronchial… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND When inhaling medication, it is essential that drug particles are delivered to all sites of lung inflammation… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The combination of short-acting beta(2)-agonists and anticholinergics in the treatment of COPD has been well… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
This study compared the bronchodilator effects of tiotropium, formoterol and both combined in chronic obstructive pulmonary… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Asthma control is improved by combining inhaled corticosteroids with long-acting beta2-agonists. However, fluctuating asthma… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The aim of this study was to investigate formoterol, an inhaled long-acting beta2-agonist, in patients with chronic obstructive… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The optimal treatment for mild asthma is uncertain. We assessed the effects of adding a long-acting inhaled beta-agonist… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
We compared the effectiveness of inhaled formoterol with that of ipratropium in the treatment of chronic obstructive pulmonary… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a double-blind study, we evaluated… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Salmeterol and formoterol are two long-acting beta2-agonists for inhalation, currently being used in clinical practice. The aim… Expand
Is this relevant?